Trial intelligence / Profile preview

IVIg in Acute Intracranial Hemorrhage

NCT02782897Phase 2Unknown

Start
Jun 2016
Primary completion
Dec 2017
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of intravenous immunoglobulin G in intracranial hemorrhage (ICH). Status: unknown.

02

Drugs

intravenous immunoglobulin G
03

Conditions

intracranial hemorrhage (ICH)

Beyond the preview

Go deeper on NCT02782897.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02782897.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call